98%
921
2 minutes
20
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/IJG.0000000000002416 | DOI Listing |
Ophthalmologie
September 2025
Augenzentrum Olching, Hauptstr. 17, 82140, Olching, Deutschland.
Background: Several therapeutic diets are known for ophthalmologic diseases. Therefore, the present study evaluates the interest of our patients in healthy and therapeutic nutrition.
Methods: In all, 100 representative patients answered a structured interview questionnaire about their nutrition behavior and interest in therapeutic diet for their ophthalmologic diseases.
Ophthalmol Glaucoma
May 2025
Department of Ophthalmology, Mayo Clinic, Jacksonville, Florida. Electronic address:
Purpose: To evaluate the rate of progression of primary open-angle glaucoma (POAG) in patients with obstructive sleep apnea (OSA) compared with non-OSA mild-moderate POAG comparators and to assess the utilization of surgical and laser intervention.
Design: A retrospective cohort study of the TriNetX US Collaborative Network was conducted by analyzing international electronic health record data from January 2004 to October 2024.
Participants: Patients in the TriNetX US Collaborative Network with a diagnosis of mild-moderate POAG, stratified with respect to OSA status.
Niger J Clin Pract
February 2025
Department of Ophthalmology, University of Nigeria Teaching Hospital, Ituku-Ozalla Enugu, Nigeria.
Background: Black Africans are more vulnerable to primary open angle glaucoma, which runs a catastrophic course. Primary trabeculectomy with anti-metabolites has been recommended as the suitable therapeutic option. Yet, a low glaucoma surgical rate (GSR) has been documented in Nigeria.
View Article and Find Full Text PDFTransl Pediatr
March 2025
Department of Ophthalmology, Children's Hospital of Fudan University, National Children's Medical Center, Shanghai, China.
Background: Coronavirus disease 2019 (COVID-19) has been coexisted with us, and corticosteroids are now recommended for patients with severe COVID-19 respiratory failure. Steroid treatments may increase intraocular pressure (IOP) and steroid-induced glaucoma (SIG). This study reported a rapid IOP elevation in a COVID-19 pneumonia child treated with systemic steroids within 3 days.
View Article and Find Full Text PDFOphthalmol Glaucoma
May 2025
Alcon, Global Health Economics and Outcomes Research (HEOR), Geneva, Switzerland.
Objective: To assess the cost-effectiveness of Hydrus Microstent combined with cataract surgery (CS) vs. CS alone for treating patients with mild to moderate primary open-angle glaucoma (POAG).
Design: Cost-utility analysis using efficacy and safety results of a pivotal randomized clinical trial.